Kazushi Iwai
About Kazushi Iwai
Kazushi Iwai is a seasoned professional in the pharmaceutical and chemical industries, currently serving as the Director of New Business Development, Regulation, Product Management, and Customer Support at ArisGlobal since 2011. He has extensive experience in marketing, sales, and project management, having previously held leadership roles at Pfizer, NTT DATA Corporation, and DuPont.
Work at ArisGlobal
Kazushi Iwai has been serving as the Director of New Business Development, Regulation, Product Management, and Customer Support at ArisGlobal since 2011. His role involves overseeing various aspects of business development and regulatory compliance within the organization. Iwai's extensive experience in the pharmaceutical sector contributes to his effectiveness in managing product development and customer support initiatives.
Previous Experience at Pfizer
Kazushi Iwai briefly worked at Pfizer as the Director of Information Technology in 2010. His tenure lasted for three months and took place in Tokyo. This role provided him with insights into the intersection of technology and the pharmaceutical industry.
Background at NTT DATA Corporation
Iwai held the position of Business Unit Director at NTT DATA Corporation from 1999 to 2006. Over the course of seven years in Tokyo, he was responsible for managing business operations and driving growth within the organization. His experience at NTT DATA contributed to his expertise in project management and strategic planning.
Experience at DuPont
Kazushi Iwai worked at DuPont for 18 years, from 1981 to 1999, as the Manager of the Crop Protection Chemical Business. His long tenure at DuPont allowed him to gain significant experience in the chemical industry, focusing on product management and market development.
Education and Expertise
Kazushi Iwai studied at 独協大学法律学部, where he achieved a degree in law from 1978 to 1981. His educational background complements his professional experience in marketing, sales, product management, and project management, particularly within the pharmaceutical and chemical sectors.